TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $95,652 | +108.0% | 6,183 | +111.2% | 0.00% | – |
Q2 2023 | $45,984 | -8.7% | 2,927 | -4.3% | 0.00% | -100.0% |
Q1 2023 | $50,380 | +15.7% | 3,057 | +9.5% | 0.00% | – |
Q4 2022 | $43,540 | +17.7% | 2,791 | -2.8% | 0.00% | – |
Q3 2022 | $37,000 | +362.5% | 2,871 | +435.6% | 0.00% | – |
Q2 2022 | $8,000 | +700.0% | 536 | +665.7% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | -75.0% | 70 | -64.3% | 0.00% | – |
Q2 2020 | $4,000 | +300.0% | 196 | +180.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | – | 70 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |